AI Verdict
AAPL has stronger fundamentals based on our AI analysis.
EMED vs AAPL Fundamental Comparison
| Metric | EMED | AAPL |
|---|---|---|
| Revenue | $570,415.0 | $143.8B |
| Net Income | $-1.3M | $42.1B |
| Net Margin | -233.1% | 29.3% |
| ROE | N/A | 47.7% |
| ROA | -233.8% | 11.1% |
| Current Ratio | 0.07x | 0.97x |
| Debt/Equity | N/A | 1.00x |
| EPS | $0.00 | $2.84 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
EMED vs AAPL: Frequently Asked Questions
Is EMED or AAPL a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), AAPL has stronger fundamentals. EMED is rated STRONG SELL (95% confidence) while AAPL is rated BUY (87% confidence). This is not investment advice.
How does EMED compare to AAPL fundamentally?
Electromedical Technologies, Inc has ROE of N/A vs Apple Inc.'s 47.7%. Net margins are -233.1% vs 29.3% respectively.
Which stock pays higher dividends, EMED or AAPL?
EMED has a dividend yield of N/A or no dividend while AAPL has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in EMED or AAPL for long term?
For long-term investing, consider that EMED has STRONG SELL rating with 95% confidence, while AAPL has BUY rating with 87% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about EMED vs AAPL?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For EMED vs AAPL, the AI consensus favors AAPL based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.